68.5 F
Hobe Sound
Thursday, January 17, 2019

Aethlon Medical, Inc.

    Aethlon Medical is focused on addressing unmet needs in global health. The Aethlon Hemopurifier® is clinical-stage immunotherapeutic device candidate to combat cancer and life-threatening viral infections. The Hemopurifier® has been designation a “Breakthrough Device” by United States Food and Drug Administration (FDA) related to the treatment of life-threatening viruses that are not addressed with approved therapies.

    Aethlon Medical is also the majority owner of Exosome Sciences, Inc., which is focused on the discovery of exosomal biomarkers to diagnose and monitor cancer and neurological disease progression.

    No posts to display